Proto Script Pharmaceutical News

News

Ticker

PSCR

ISIN

US74373V1052

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Proto Script Pharmaceutical Eulerpool News

Proto Script Pharmaceutical Stock News

Proto Script Pharmaceutical is being monitored by journalists and investors worldwide. We gather the latest Proto Script Pharmaceutical news here.

March 11·
Nasdaq
Public Storage's 6.45% Cumulative Preferred Stock, Series F Ex-Dividend Reminder
March 11·
Nasdaq
Why Tesla Stock Tumbled Again Today
March 11·
Nasdaq
U.S. drillers add oil and gas rigs for ninth time in 10 weeks -Baker Hughes
March 11·
Nasdaq
Why Shares of Futu Are Falling
March 11·
Nasdaq
5 Reasons to Add ABM Industries (ABM) Stock to Your Portfolio
March 10·
Nasdaq
No breakthrough in Russia-Ukraine talks as besieged civilians endure bombardments
March 10·
Nasdaq
Readying for a 2022 Lift-Off: 3 Travel and Tourism Stocks to Follow this Year
March 10·
Nasdaq
TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call Transcript
March 10·
Nasdaq
SuRo Capital Corp. (SSSS) Q4 2021 Earnings Call Transcript
March 9·
Nasdaq
EXPLAINER-Why Japan's power sector depends so much on LNG
March 9·
Nasdaq
GLOBAL MARKETS-Asian shares surge as Russia-Ukraine talks buoy sentiment
March 9·
Nasdaq
Points.com (PCOM) Surpasses Q4 Earnings and Revenue Estimates
March 9·
Nasdaq
Crowdstrike, Asana Cap a Wild Day on Wall Street
March 7·
Nasdaq
Why Black Knight Dropped 24.7% in February
March 7·
Nasdaq
Noteworthy Monday Option Activity: SBUX, LVS, ULTA
March 6·
CNBC
Netflix suspends service in Russia
March 5·
Nasdaq
Is Okta a Buy After Losing $848 Million Last Year?
March 5·
Nasdaq
3 Reasons This HealthCare Stock Is a Great Buy in 2022
March 5·
Nasdaq
Can You Buy Crypto Through a Roth IRA?
March 5·
Nasdaq
Better Buy: fuboTV vs. Skillz

Proto Script Pharmaceutical Stock Press Releases

Proto Script Pharmaceutical regularly publishes news on the company's website that are relevant for investors.

Proto Script Pharmaceutical News 2026

This page contains all current news, analysis and press releases for Proto Script Pharmaceutical stock (PSCR, ISIN: US74373V1052). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Proto Script Pharmaceutical.

Proto Script Pharmaceutical Stock

Proto Script Pharmaceutical Proto Script Pharmaceutical Corp is an American biotechnology company specializing in the development and manufacture of innovative, high-quality drugs. The company is focused on researching new breakthrough technologies in drug manufacturing to find potential cures and treat diseases. Their business model is based on producing medications that are highly effective and of high quality while also being cost-effective and patient-friendly. They collaborate closely with biotechnology companies and academic institutions to acquire the best technologies and develop effective and innovative drugs. They have products in the areas of neurology, endocrine health, and oncology. They have also entered into partnerships with other companies to expand and further develop their products. Overall, Proto Script Pharmaceutical Corp is a groundbreaking company in the biotechnology field with decades of experience in drug development and a commitment to improving the lives of millions of people worldwide.